The PK/PD Study of SHR2285 Tablets in Healthy Subjects

NCT03769831 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Thrombosis

Interventions

DRUG: SHR2285
DRUG: Placebo

Sponsor

Jiangsu HengRui Medicine Co., Ltd.